326 related articles for article (PubMed ID: 32722234)
1. Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators.
M F Gonçalves B; S P Cardoso D; U Ferreira MJ
Molecules; 2020 Jul; 25(15):. PubMed ID: 32722234
[TBL] [Abstract][Full Text] [Related]
2. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
4. Marine Natural Products as Models to Circumvent Multidrug Resistance.
Long S; Sousa E; Kijjoa A; Pinto MM
Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
[TBL] [Abstract][Full Text] [Related]
5. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
7. ATP-binding cassette efflux transporters and MDR in cancer.
Pote MS; Gacche RN
Drug Discov Today; 2023 May; 28(5):103537. PubMed ID: 36801375
[TBL] [Abstract][Full Text] [Related]
8. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
9. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity.
Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA
ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726
[TBL] [Abstract][Full Text] [Related]
10. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
11. Role of ABC transporters in cancer chemotherapy.
Sun YL; Patel A; Kumar P; Chen ZS
Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384
[TBL] [Abstract][Full Text] [Related]
12. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
[TBL] [Abstract][Full Text] [Related]
13. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
14. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters.
Di Pietro A; Conseil G; Pérez-Victoria JM; Dayan G; Baubichon-Cortay H; Trompier D; Steinfels E; Jault JM; de Wet H; Maitrejean M; Comte G; Boumendjel A; Mariotte AM; Dumontet C; McIntosh DB; Goffeau A; Castanys S; Gamarro F; Barron D
Cell Mol Life Sci; 2002 Feb; 59(2):307-22. PubMed ID: 11915946
[TBL] [Abstract][Full Text] [Related]
15. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
17. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.
Teodori E; Braconi L; Manetti D; Romanelli MN; Dei S
Curr Top Med Chem; 2022; 22(31):2535-2569. PubMed ID: 36284399
[TBL] [Abstract][Full Text] [Related]
18. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.
Choi YH; Yu AM
Curr Pharm Des; 2014; 20(5):793-807. PubMed ID: 23688078
[TBL] [Abstract][Full Text] [Related]
19. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
20. Overcoming Multidrug Resistance (MDR): Design, Biological Evaluation and Molecular Modelling Studies of 2,4-Substituted Quinazoline Derivatives.
Braconi L; Teodori E; Contino M; Riganti C; Bartolucci G; Manetti D; Romanelli MN; Perrone MG; Colabufo NA; Guglielmo S; Dei S
ChemMedChem; 2022 Jun; 17(12):e202200027. PubMed ID: 35416421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]